InVivo Therapeutics Corp EV/EBIT
Quel est le EV/EBIT de InVivo Therapeutics Corp?
Le EV/EBIT de InVivo Therapeutics Holdings Corp est N/A
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à InVivo Therapeutics Corp
Que fait InVivo Therapeutics Corp?
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Entreprises avec ev/ebit similaire à InVivo Therapeutics Corp
- Aurum Resources Ltd a EV/EBIT de N/A
- Aduro BioTech a EV/EBIT de N/A
- Quintana Services a EV/EBIT de N/A
- Maple Peak Investments a EV/EBIT de N/A
- Inovio Pharmaceuticals Inc a EV/EBIT de N/A
- Zoom Telephonics a EV/EBIT de N/A
- InVivo Therapeutics Corp a EV/EBIT de N/A
- Natures Hemp a EV/EBIT de N/A
- Pulmatrix Inc a EV/EBIT de N/A
- Techindia Nirman a EV/EBIT de N/A
- Larimar Therapeutics a EV/EBIT de N/A
- Epigenomics AG a EV/EBIT de N/A
- Internet of Things a EV/EBIT de N/A